Stock Forecast Chart
Stock Price Prediction Summary
Forecast Score Based on 2 Weeks
Based on our forecast, the price of ARDS will remain same at 0 over the next 2 Weeks and hit $0.00 by Thursday, September 3, 2026. In that time frame, ARDS's share price is expected to range between $0.00 and $0.00.
BearishAverageBullish| Date | Predicted Lower | Predicted | Predicted Upper |
|---|---|---|---|
| Sep 3, 2026 | 0.00 | 0.00 | 0.00 |
| Sep 2, 2026 | 0.00 | 0.00 | 0.00 |
| Sep 1, 2026 | 0.00 | 0.00 | 0.00 |
| Aug 31, 2026 | 0.00 | 0.00 | 0.00 |
| Aug 28, 2026 | 0.00 | 0.00 | 0.00 |
| Aug 27, 2026 | 0.00 | 0.00 | 0.00 |
| Aug 26, 2026 | 0.00 | 0.00 | 0.00 |
| Aug 25, 2026 | 0.00 | 0.00 | 0.00 |
| Aug 24, 2026 | 0.00 | 0.00 | 0.00 |
| Aug 21, 2026 | 0.00 | 0.00 | 0.00 |
ARDS shares remained flat 0 in Thursday, August 20, 2026's trading session, starting and closing at a previous close of $0.00 to move at $0.00. The stock demonstrated notable intraday movement (see ARDS's key stats for a full breakdown), fluctuating between $0.00 and $0.00, a 0 trading range. While recent weeks have seen some volatility, ARDS has managed to secure a -95.74% drop over the past 2 weeks. The neutral price movement was accompanied by increased trading volume, with approximately 1K shares changing hands, 901 more than the previous session. This amounted to $0.10 in total market activity.
Will ARDS Continue Its Upward Trend?
According to analyst ratings and projections for ARDS, Aridis Pharmaceuticals, Inc. shares are anticipated to increase by +88.23%, potentially reaching $0.00 per share by September 3, 2026. Short-term technical indicators currently suggest a neutral sentiment for ARDS. For deeper insights, view our sentiment analysis on AAPL covering social and institutional perspectives. However, the stock has recorded 3 positive trading days within the past 30 sessions. Based on the ARDS stock forecast, now is a good time to buy ARDS stock because its current trading price is 0 our predicted value, hinting at a possible . For deeper insights, view our sentiment analysis on ARDS covering social and institutional perspectives.
ARDS Technical Momentum: Overbought, Oversold, or Neutral?
An analysis of Relative Strength Index (RSI) indicators provides insight into ARDS's momentum. Short-term RSIs (9, 14, and 20-day figures ranging from 39.15% to 45.30%) suggest mixed signals, with the stock in a neutral to slightly bearish momentum phase. The 50-day RSI, at 48.47%, suggests a neutral medium-term outlook. Additionally, the 100-day RSI, at 48.40%, maintains a neutral outlook for the long term. Insights into ARDS's shareholder base show how institutional investors are positioning themselves during these momentum shifts
Aridis Pharmaceuticals Short-Term Forecasts
ARDS Forecast For Next 5 Days
Our algorithm anticipates Aridis Pharmaceuticals (ARDS) stock could hit $0.00 by Aug 28, 2026. This represents a +100.00% fall from today's price, following a -6.98% change over the past five days.
ARDS Forecast For Next 30 Days
Based on analysis of market trends, the outlook for Aridis Pharmaceuticals, Inc. (ARDS) stock over the next 30 days is largely negative. Price forecasts suggest an average target of $0.00, which would mean a -100.00% decrease from the current price of $0.00. Projections for this period range from a high of $0.00 to a low of $0.00.
ARDS Forecast For Next 90 Days
Our proprietary market analysis suggests predictions for Aridis Pharmaceuticals's price over the next three months point to a drop. ARDS stock is expected to peak at $0.02 on Sep 30, 2026 before potentially dipping to $0.00 on Nov 20, 2026. On average, ARDS is likely to trade around $0.00 in the coming 90 days.
Aridis Pharmaceuticals Stock Forecast 2025
Based on our predictive models, Aridis Pharmaceuticals (ARDS) is expected to trade between $0.00 and $0.02 throughout 2026. This would result in an average price of $0.00, potentially offering investors a -100.00% return from current levels.
Aridis Pharmaceuticals, Inc. Monthly Forecast 2026–2027
August 2026
According to our latest forecast models, Aridis Pharmaceuticals, Inc. (ARDS) is positioned to show a strong performance in August 2026. The price is predicted to move between $0.00 and $0.02, settling at an average of $0.00. This could translate to a -100.00% loss.
September 2026
Based on current market signals, Aridis Pharmaceuticals, Inc. is projected to trend september 2026. We forecast a trading range from $0.00 to $0.02, with a likely average price of $0.00. Investors could expect a potential return of -100.00%.
October 2026
Our predictive algorithms indicate Aridis Pharmaceuticals, Inc. stock may see a shift in October 2026. The expected range spans $0.00–$0.02, with an average target of $0.00. This represents a cautious outlook and a possible loss of -100.00%.
November 2026
Analyzing established trends, Aridis Pharmaceuticals, Inc. looks set to move in November 2026. Projections place the stock between $0.00 and $0.02, averaging around $0.00. This suggests a -100.00% loss from current levels.
December 2026
Market indicators suggest Aridis Pharmaceuticals, Inc. could experience notable changes during December 2026. Prices could fluctuate within $0.00 to $0.02, with a midpoint forecast of $0.00. The stock might deliver a -100.00% loss.
January 2027
Forecasting for January 2027, models estimate that Aridis Pharmaceuticals, Inc. may undergo key fluctuations. If trends hold, the stock might trade between $0.00 and $0.02, averaging $0.00. This signals a cautious trajectory with potential returns around -100.00%.
February 2027
According to our latest forecast models, Aridis Pharmaceuticals, Inc. (ARDS) is positioned to show a strong performance in February 2027. The price is predicted to move between $0.00 and $0.02, settling at an average of $0.00. This could translate to a -100.00% loss.
March 2027
Based on current market signals, Aridis Pharmaceuticals, Inc. is projected to trend march 2027. We forecast a trading range from $0.00 to $0.02, with a likely average price of $0.00. Investors could expect a potential return of -100.00%.
April 2027
Our predictive algorithms indicate Aridis Pharmaceuticals, Inc. stock may see a shift in April 2027. The expected range spans $0.00–$0.02, with an average target of $0.00. This represents a cautious outlook and a possible loss of -100.00%.
May 2027
Analyzing established trends, Aridis Pharmaceuticals, Inc. looks set to move in May 2027. Projections place the stock between $0.00 and $0.02, averaging around $0.00. This suggests a -100.00% loss from current levels.
June 2027
Market indicators suggest Aridis Pharmaceuticals, Inc. could experience notable changes during June 2027. Prices could fluctuate within $0.00 to $0.02, with a midpoint forecast of $0.00. The stock might deliver a -100.00% loss.
July 2027
Forecasting for July 2027, models estimate that Aridis Pharmaceuticals, Inc. may undergo key fluctuations. If trends hold, the stock might trade between $0.00 and $0.02, averaging $0.00. This signals a cautious trajectory with potential returns around -100.00%.
August 2027
According to our latest forecast models, Aridis Pharmaceuticals, Inc. (ARDS) is positioned to show a strong performance in August 2027. The price is predicted to move between $0.00 and $0.02, settling at an average of $0.00. This could translate to a -100.00% loss.
ARDS's history of dividends and stock splits also plays a role in long-term investor confidence.